Authors Cluzeau T, Furstoss N, Savy C, El Manaa W, Zerhouni M, Blot L, Calleja A, Dufies M, Dubois A, Ginet C, Mounier N, Garnier G, Raynaud S, Rohrlich PS, Peterlin P, Stamatoullas A, Chermat F, Fenaux P, Jacquel A, Robert G, Auberger P
International journal of molecular sciences Dec 2019
Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia.Authors Muselli F, Peyron JF, Mary D
International journal of molecular sciences Nov 2019
GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism.Authors Mondragón L, Mhaidly R, De Donatis GM, Tosolini M, Dao P, Martin AR, Pons C, Chiche J, Jacquin M, Imbert V, Proïcs E, Boyer L, Doye A, Luciano F, Neels JG, Coutant F, Fabien N, Sormani L, Rubio-Patiño C, Bossowski JP, Muller F, Marchetti S, Villa E, Peyron JF, Gaulard P, Lemonnier F, Asnafi V, Genestier L, Benhida R, Fournié JJ, Passeron T, Ricci JE, Verhoeyen E
Cancer cell Aug 2019
Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5.Authors Giuliano S, Dufies M, Ndiaye PD, Viotti J, Borchiellini D, Parola J, Vial V, Cormerais Y, Ohanna M, Imbert V, Chamorey E, Rioux-Leclercq N, Savina A, Ferrero JM, Mograbi B, Pagès G
Theranostics Jan 2019
Co-targeting intracellular pH and essential amino acid uptake cooperates to induce cell death of T-ALL/LL cells.Authors Imbert V, Nebout M, Mary D, Endou H, Wempe MF, Supuran CT, Winum JY, Peyron JF
Leukemia & lymphoma Feb 2018
Metformin, an Anti-diabetic Drug to Target Leukemia.Authors Biondani G, Peyron JF
Frontiers in endocrinology Jan 2018
Mitochondrial Transfer in the Leukemia Microenvironment.Authors Griessinger E, Moschoi R, Biondani G, Peyron JF
Trends in cancer Dec 2017
BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemia.Authors Vidal V, Robert G, Goursaud L, Durand L, Ginet C, Karsenti JM, Luciano F, Gastaud L, Garnier G, Braun T, Hirsch P, Raffoux E, Nloga AM, Padua RA, Dombret H, Rohrlich P, Ades L, Chomienne C, Auberger P, Fenaux P, Cluzeau T
Oncotarget Jul 2017
Iron chelation: an adjuvant therapy to target metabolism, growth and survival of murine PTEN-deficient T lymphoma and human T lymphoblastic leukemia/lymphoma.Authors Benadiba J, Rosilio C, Nebout M, Heimeroth V, Neffati Z, Popa A, Mary D, Griessinger E, Imbert V, Sirvent N, Peyron JF
Leukemia & lymphoma Jun 2017
NF-κB in Hematological Malignancies.Authors Imbert V, Peyron JF
Biomedicines May 2017